WANG et al. (Wang et al., 2017) used network pharmacology to analyze the potential targets of H. diffusa-Astragalus membranaceus for the treatment of colorectal cancer, and found that the core target also contained CTNNB1. This evidence concerns the gene CTNNB1 and colorectal cancer.